Flu Season Alert!Alerta de temporada de influenza:
Don’t let germs win this season – protect yourself and your family!
The flu vaccine is your best defense against flu and related complications – PLUS, it is a covered benefit for Texas Children’s Health Plan members! Learn more!
¡No permitas que los gérmenes ganen esta temporada! ¡Protégete a ti y a tu familia!
La vacuna contra la influenza es tu mejor defensa contra la influenza y sus complicaciones. Además, ¡es un beneficio cubierto para los miembros de Texas Children's Health Plan! Aprende más
Change in Preferred Drug List (PDL) Status for Beta Agonist Drug Class
Date: January 13, 2025
Attention: All Providers
Effective date: January 3, 2025
Call to action: Effective January 3, 2025, generic Levalbuterol inhalation solution will now be preferred. This is in response to discontinuation of brand product Xopenex by the manufacturer.
The preferred status of the brand name Xopenex will not change to allow any remaining stock to be used.
How this impacts providers: The change will allow providers to prescribe the generic without requiring preferred drug list (PDL) prior authorization at this time and continue accessing necessary medication for their patients.
Next step for providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
